Realistic Mass Casualty Medical Simulation Capabilities RFI

The Defense Advanced Research Projects Agency’s Biological Technologies Office is seeking information on the capability to plan, resource, execute, and assess high-fidelity, large-scale mass casualty medical simulation events involving 50 to 200 simulated patients within a 72-hour window. This Request for Information, designated DARPA-SN-26-79, is not a solicitation for proposals or a commitment to fund; it is purely an information-gathering effort to assess existing industry, government, and emergency response capabilities in replicating realistic battlefield medical scenarios. Respondents are asked to provide white papers no longer than three pages detailing organizational experience, simulation execution methods including moulage, live actors, physiology-enabled manikins, and Class VIII medical consumables, as well as data collection and assessment techniques and cost estimates. Augmented, virtual, and mixed reality solutions are within scope, and supporting visual materials such as videos or photos may be submitted separately. All submissions must be sent via email to MASCAL_RFI@darpa.mil as PDFs by May 31, 2026, and must not include classified information. Proprietary data must be clearly labeled, and respondents must confirm the U.S. Government’s right to use all submitted visuals. The point of contact is Dr. Jeremy Pamplin of DARPA/BTO, and responses are to be addressed to the agency’s office in Arlington, Virginia. No contract clauses, evaluation factors, payment details, or award mechanisms apply, as this is a pre-solicitation market research action under FAR 15.101(c). The NAICS code 541714 is associated with this activity, indicating the focus on research and development in the life sciences and technology sectors relevant to defense medical readiness.